Blood test may personalize heart disease treatment

NCT ID NCT04755413

Ongoing Disease control Sponsor: Emory University Source: ClinicalTrials.gov ↗

First seen Nov 21, 2025 · Last updated May 01, 2026 · Updated 19 times

Summary

This study looks at whether using a blood test to measure certain proteins (biomarkers) can help doctors create a more personalized treatment plan for people with coronary artery disease. About 276 adults with stable heart disease will be split into two groups: one gets standard care, the other gets treatment adjusted based on their biomarker levels. The goal is to see if the personalized approach lowers these biomarker levels and reduces the risk of heart attacks, strokes, or other complications.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Emory Johns Creek Hospiatl

Atlanta, Georgia, 30097, United States
Emory Saint Joseph's Hospital

Atlanta, Georgia, 30342, United States
Emory University Hospital

Atlanta, Georgia, 30322, United States
Emory University Hospital Midtown

Atlanta, Georgia, 30308, United States
The Emory Clinic

Atlanta, Georgia, 30324, United States

Conditions

Explore the condition pages connected to this study.

CORONARY ARTERY DISEASE